Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 745 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Pasithea Therapeutics Corp.
Market Cap
$14.77M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$14.57M
Operating Margin
-30.39%
TTM Avg
-233.67%
3Y Avg
-448.22%
5Y Avg
-530.52%
Market Cap
$14.38M
Operating Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$15.34M
Operating Margin
-56.17%
TTM Avg
-72.17%
3Y Avg
-80.90%
5Y Avg
-88.24%
Market Cap
$15.42M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-79.33%
Market Cap
$13.83M
Operating Margin
-1053.14%
TTM Avg
-1090.26%
3Y Avg
-1143.76%
5Y Avg
-1293.19%
Market Cap
$15.72M
Operating Margin
-3939.06%
TTM Avg
-1969.53%
3Y Avg
-984.76%
5Y Avg
-656.51%
Market Cap
$13.77M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pasithea Therapeutics Corp. (KTTA) | $14.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| Pulsenmore Ltd. Ordinary Shares (PLSM)vs › | $14.57M | -30.39% | -233.67% | -448.22% | -530.52% |
| Obsidian Therapeutics Inc. (OBX)vs › | $14.38M | N/A | N/A | N/A | N/A |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.34M | -56.17% | -72.17% | -80.90% | -88.24% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.42M | 0.00% | 0.00% | 0.00% | -79.33% |
| IN8bio, Inc. (INAB)vs › | $13.91M | 0.00% | 0.00% | 0.00% | 0.00% |
| Sintx Technologies, Inc. (SINT)vs › | $13.83M | -1053.14% | -1090.26% | -1143.76% | -1293.19% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.72M | -3939.06% | -1969.53% | -984.76% | -656.51% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $13.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| Vyome Holdings, Inc. (HIND)vs › | $13.72M | -859.22% | -477.88% | -341.34% | -316.87% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | -12988.03% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
